Results revealed racial inequities in hospitalization and treatment delays among patients with mpox who received tecovirimat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback